131 related articles for article (PubMed ID: 8315895)
1. [Basic and clinical studies of serum CA195 antigen assay with "BL-CA195" kit].
Kobayashi M; Yamaguchi A; Imai T; Otake H; Igarashi H; Hatori N; Tomiyoshi K; Inoue T; Endo K; Sakahara H
Kaku Igaku; 1993 Apr; 30(4):441-7. PubMed ID: 8315895
[TBL] [Abstract][Full Text] [Related]
2. [Basic study of CA125 measurement using a newly developed "SD-8729" IRMA kit].
Yamaguchi A; Kobayashi M; Imai T; Otake H; Matsubara K; Hatori N; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1993 Oct; 30(10):1245-52. PubMed ID: 8264116
[TBL] [Abstract][Full Text] [Related]
3. [Basic studies of BALL ELSA CA125-II KIT for detection of serum cancer antigen 125].
Kakizaki J; Miyazaki T; Maeda T
Kaku Igaku; 1993 Jul; 30(7):807-12. PubMed ID: 8377304
[TBL] [Abstract][Full Text] [Related]
4. [A basic and clinical evaluation of a new immunoradiometric assay kit for human serum tissue polypeptide antigen (TPA)].
Shimojo K; Watanabe N; Sakai S; Kobayashi M; Ohtake H; Hatori N; Fukasawa K; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1996 Jun; 33(6):655-61. PubMed ID: 8741511
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of a cytokeratin 19 assay kit "BALL ELSA CYFRA21-1"].
Sakahara H; Kousaka T; Hattori N; Hosono M; Kobayashi H; Shirato M; Yao Z; Konishi J
Kaku Igaku; 1993 Dec; 30(12):1475-9. PubMed ID: 7509008
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of carbohydrate antigen 195 and carcinoembryonic antigen for the diagnosis of pancreatic carcinoma.
Andicoechea A; Vizoso F; Alexandre E; Martínez A; Cruz Díez M; Riera L; Martinez E; Ruibal A
World J Surg; 1999 Mar; 23(3):227-31; discussion 231-2. PubMed ID: 9933690
[TBL] [Abstract][Full Text] [Related]
7. Behavior of tumor markers CA19.9, CA195, CAM43, CA242, and TPS in the diagnosis and follow-up of pancreatic cancer.
Banfi G; Zerbi A; Pastori S; Parolini D; Di Carlo V; Bonini P
Clin Chem; 1993 Mar; 39(3):420-3. PubMed ID: 8448851
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of a new monoclonal antibody defined antigen CA195 as a tumor marker in colorectal cancer.
Shiue JW; Tam TN; Lai KH; Jeng FS; Liu RS; Yeh SH; Lee SD; Tsai YT
Zhonghua Yi Xue Za Zhi (Taipei); 1989 Oct; 44(4):223-8. PubMed ID: 2634457
[TBL] [Abstract][Full Text] [Related]
9. [Basic and clinical studies on serum cytokeratin 19 fragment assay using Centocor CYFRA 21-1 kit in patients with lung cancer].
Hamase A; Sugimoto Y; Maeda M; Kitani H; Fukuchi M
Kaku Igaku; 1994 Aug; 31(8):969-76. PubMed ID: 7523748
[TBL] [Abstract][Full Text] [Related]
10. [The evaluation of the newly produced assay kit for the cytokeratin fragment, "ball ELSA CYFRA21-1"].
Kimura Y; Ata M; Nakamura S; Fujii T; Kawamura T; Tanada S; Hamamoto K
Kaku Igaku; 1994 Feb; 31(2):199-206. PubMed ID: 7509886
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of CA72-4, CA195 and carcinoembryonic antigen in patients with gastrointestinal malignancies.
Kornek GV; Depisch D; Rosen HR; Temsch EM; Scheithauer W
J Cancer Res Clin Oncol; 1992; 118(4):318-20. PubMed ID: 1374412
[TBL] [Abstract][Full Text] [Related]
12. Construction of an immunoradiometric assay for ovarian cancer associated antigen CA125 recognizing different antigenic determinant.
Saga T; Endo K; Nakashima T; Awaji T; Koizumi M; Kawamura Y; Watanabe Y; Konishi J; Nonogaki H; Nanbu Y
Acta Obstet Gynecol Scand; 1990; 69(2):175-81. PubMed ID: 1696770
[TBL] [Abstract][Full Text] [Related]
13. [Basic and clinical studies on SPan-1 RIABEAD kit: usefulness in patients with pancreatic and biliary tract cancer].
Watanabe Y; Endo K; Nakajima K; Hattori N; Sakahara H; Saga T; Nakai T; Hosono M; Yao ZS; Baba N
Kaku Igaku; 1989 Dec; 26(12):1559-65. PubMed ID: 2622087
[No Abstract] [Full Text] [Related]
14. [Evaluation of BEKI TPS radioassay kit as a one-step immunoradiometric assay utilizes monoclonal and polyclonal antibodies specific for serum tissue polypeptide antigen].
Hamase A; Kawanaka M; Kitani H; Fukuchi M
Kaku Igaku; 1994 Aug; 31(8):995-1003. PubMed ID: 7933689
[TBL] [Abstract][Full Text] [Related]
15. [Comparative assessment of the characteristics in various assay kits for prostate specific antigen].
Akiyama A; Yamamoto S; Hokoishi F; Ogawa M; Aizawa T; Matsumoto T; Miki M
Nihon Hinyokika Gakkai Zasshi; 1993 Dec; 84(12):2103-8. PubMed ID: 7508530
[TBL] [Abstract][Full Text] [Related]
16. [Basic study of CA549, a new tumor marker for breast cancer, and evaluation of its clinical usefulness].
Yamaguchi A; Ushigome M; Imai T; Otake H; Igarashi H; Hatori N; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1993 Mar; 30(3):317-22. PubMed ID: 8479100
[TBL] [Abstract][Full Text] [Related]
17. In vitro effect of contrast agents during immunoradiometric assay for tumour-associated antigens.
Watanabe N; Oriuchi N; Higuchi T; Yukihiro M; Fukushima Y; Tomiyoshi K; Hirano T; Inoue T; Endo K
Nucl Med Commun; 1998 Jan; 19(1):63-70. PubMed ID: 9515548
[TBL] [Abstract][Full Text] [Related]
18. [Fundamental and clinical evaluation of IRMA for serum pancreatic oncofetal antigen (POA)].
Murakami M; Fukuchi M
Kaku Igaku; 1988 Feb; 25(2):161-9. PubMed ID: 3164428
[No Abstract] [Full Text] [Related]
19. [Basic and clinical evaluation of a novel immunoradiometric assay kit for free thyroxine].
Misaki T; Kousaka T; Miyamoto S; Takeuchi R; Kasagi K; Konishi J
Kaku Igaku; 1994 Jun; 31(6):629-35. PubMed ID: 8072238
[TBL] [Abstract][Full Text] [Related]
20. [Fundamental and clinical evaluation of ELSA CA 72-4 kit for serum CA 72-4 antigen].
Omori S; Murakami M; Fukuchi M
Kaku Igaku; 1990 Jun; 27(6):667-75. PubMed ID: 2214330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
